Skip to main content
. 2021 Oct 25;14:249. doi: 10.1186/s12920-021-01037-3

Table 3.

Relationships of PDX1 and MC4R polymorphisms with T2DM risk stratified by age and sex

Gene SIP Model Genotype > 60 ≤ 60 Male Female
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p

PDX1

rs9581943

Allele G 1.00 1.00 1.00 1.00
A 0.99 (0.76–1.28) 0.919 0.84 (0.65–1.09) 0.180 0.94 (0.75–1.16) 0.544 0.87 (0.62–1.22) 0.424
Codominant GG 1.00 1.00 1.00 1.00
AA 1.05 (0.60–1.84) 0.852 0.79 (0.45–1.38) 0.409 1.05 (0.67–1.66) 0.829 0.77 (0.37–1.60) 0.481
AG 0.86 (0.58–1.27) 0.439 0.66 (0.45–0.98) 0.039 0.73 (0.5–1.00) 0.049 0.85 (0.51–1.40) 0.516
Dominant GG 1.00 1.00 1.00 1.00
AA-AG 0.90 (0.63–1.30) 0.580 0.69 (0.48–1.00) 0.049 0.80 (0.59–1.07) 0.130 0.83 (0.51–1.34) 0.439
Recessive AG-GG 1.00 1.00 1.00 1.00
AA 1.14 (0.67–1.92) 0.634 0.99 (0.59–1.67) 0.982 1.24 (0.81–1.89) 0.330 0.84 (0.43–1.66) 0.620
Additive 0.98 (0.76–1.27) 0.873 0.83 (0.63–1.08) 0.156 0.94 (0.76–1.16) 0.554 0.87 (0.62–1.22) 0.421

PDX1

rs7981781

Allele G 1.00 1.00 1.00 1.00
A 0.96 (0.75–1.23) 0.753 1.08 (0.84–1.40) 0.542 0.94 (0.76–1.16) 0.558 1.22 (0.88–1.70) 0.241
Codominant GG 1.00 1.00 1.00 1.00
AA 1.00 (0.60–1.67) 0.999 1.23 (0.72–2.08) 0.449 0.96 (0.64–1.46) 0.856 1.46 (0.72–2.96) 0.300
AG 0.89 (0.59–1.35) 0.584 0.91 (0.61–1.35) 0.628 0.70 (0.50–0.97) 0.033 1.41 (0.83–2.39) 0.203
Dominant GG 1.00 1.00 1.00 1.00
AA-AG 0.92 (0.62–1.36) 0.683 0.98 (0.67–1.43) 0.925 0.77 (0.56–1.05) 0.096 1.42 (0.86–2.35) 0.172
Recessive AG-GG 1.00 1.00 1.00 1.00
AA 1.07 (0.69–1.68) 0.757 1.30 (0.81–2.09) 0.281 1.19 (0.83–1.72) 0.352 1.18 (0.63–2.20) 0.615
Additive 0.99 (0.77–1.27) 0.928 1.07 (0.83–1.38) 0.603 0.94 (0.77–1.16) 0.567 1.24 (0.88–1.75) 0.225

MC4R

rs6567160

Allele T 1.00 1.00 1.00 1.00
C 1.32 (0.99–1.75) 0.060 0.77 (0.57–1.04) 0.091 0.96 (0.7–1.23) 0.756 1.16 (0.79–1.71) 0.460
Codominant TT 1.00 1.00 1.00 1.00
CC 1.81 (0.91–3.58) 0.091 0.33 (0.13–0.81) 0.015 0.70 (0.37–1.32) 0.271 1.41 (0.57–3.54) 0.459
CT 1.22 (0.82–1.80) 0.322 0.96 (0.65–1.40) 0.815 1.11 (0.81–1.52) 0.522 1.08 (0.65–1.81) 0.758
Dominant TT 1.00 1.00 1.00 1.00
CC-CT 1.31 (0.91–1.89) 0.144 0.84 (0.58–1.21) 0.340 1.04 (0.77–1.39) 0.820 1.14 (0.70–1.84) 0.596
Recessive CT-TT 1.00 1.00 1.00 1.00
CC 1.68 (0.86–3.28) 0.129 0.33 (0.14–0.81) 0.016 0.68 (0.36–1.26) 0.215 1.37 (0.56–3.37) 0.489
Additive 1.29 (0.97–1.71) 0.077 0.77 (0.57–1.04) 0.085 0.96 (0.76–1.23) 0.760 1.14 (0.79–1.66) 0.484

MC4R

rs663129

Allele G 1.00 1.00 1.00 1.00
A 1.32 (0.99–1.75) 0.060 0.79 (0.59–1.07) 0.125 0.98 (0.77–1.25) 0.852 1.16 (0.79–1.71) 0.460
Codominant GG 1.00 1.00 1.00 1.00
AA 1.81 (0.91–3.58) 0.091 0.33 (0.13–0.82) 0.017 0.71 (0.38–1.33) 0.284 1.41 (0.57–3.54) 0.459
AG 1.22 (0.82–1.80) 0.322 0.99 (0.68–1.45) 0.966 1.14 (0.83–1.55) 0.424 1.08 (0.65–1.81) 0.758
Dominant GG 1.00 1.00 1.00 1.00
AA-AG 1.31 (0.91–1.89) 0.144 0.87 (0.60–1.25) 0.441 1.06 (0.79–1.43) 0.704 1.14 (0.70–1.84) 0.596
Recessive AG-GG 1.00 1.00 1.00 1.00
AA 1.68 (0.86–3.28) 0.129 0.33 (0.14–0.81) 0.016 0.68 (0.36–1.26) 0.215 1.37 (0.56–3.37) 0.489
Additive 1.29 (0.97–1.71) 0.077 0.78 (0.58–1.06) 0.116 0.98 (0.77–1.24) 0.854 1.14 (0.79–1.66) 0.484

MC4R

rs17782313

Allele T 1.00 1.00 1.00 1.00
C 1.32 (0.99–1.75) 0.060 0.81 (0.60–1.09) 0.167 0.98 (0.77–1.26) 0.901 1.18 (0.80–1.74) 0.403
Codominant TT 1.00 1.00 1.00 1.00
CC 1.81 (0.91–3.58) 0.091 0.34 (0.14–0.83) 0.018 0.71 (0.38–1.34) 0.291 1.43 (0.57–3.58) 0.443
CT 1.22 (0.82–1.80) 0.322 1.03 (0.71–1.51) 0.867 1.15 (0.84–1.58) 0.378 1.12 (0.67–1.87) 0.660
Dominant TT 1.00 1.00 1.00 1.00
CC-CT 1.31 (0.91–1.89) 0.144 0.90 (0.62–1.30) 0.569 1.07 (0.80–1.44) 0.648 1.17 (0.73–1.90) 0.515
Recessive CT-TT 1.00 1.00 1.00 1.00
CC 1.68 (0.86–3.28) 0.129 0.33 (0.14–0.81) 0.016 0.68 (0.36–1.26) 0.215 1.37 (0.56–3.37) 0.489
Additive 1.29 (0.97–1.71) 0.077 0.80 (0.59–1.09) 0.159 0.99 (0.77–1.25) 0.903 1.16 (0.80–1.69) 0.426

MC4R

rs12969709

Allele C 1.00 1.00 1.00 1.00
A 1.13 (0.85–1.51) 0.406 0.78 (0.57–1.06) 0.111 0.91 (0.71–1.16) 0.449 1.03 (0.69–1.53) 0.884
Codominant CC 1.00 1.00 1.00 1.00
AA 1.37 (0.67–2.80) 0.396 0.27 (0.10–0.75) 0.012 0.58 (0.29–1.15) 0.117 1.02 (0.39–2.70) 0.965
AC 1.12 (0.76–1.65) 0.583 0.98 (0.67–1.43) 0.900 1.06 (0.77–1.45) 0.726 1.05 (0.63–1.75) 0.867
Dominant CC 1.00 1.00 1.00 1.00
AA-AC 1.16 (0.80–1.67) 0.442 0.85 (0.59–1.23) 0.397 0.98 (0.72–1.32) 0.879 1.04 (0.64–1.69) 0.871
Recessive AC-CC 1.00 1.00 1.00 1.00
AA 1.31 (0.65–2.66) 0.449 0.27 (0.10–0.75) 0.012 0.57 (0.29–1.11) 0.099 1.01 (0.39–2.62) 0.989
Additive 1.14 (0.86–1.53) 0.361 0.77 (0.56–1.05) 0.098 0.91 (0.71–1.16) 0.451 1.03 (0.70–1.51) 0.893

MC4R

rs11663816

Allele T 1.00 1.00 1.00 1.00
C 1.21 (0.90–1.61) 0.203 0.75 (0.55–1.02) 0.067 0.92 (0.72–1.17) 0.488 1.07 (0.72–1.60) 0.727
Codominant TT 1.00 1.00 1.00 1.00
CC 1.78 (0.85–3.73) 0.127 0.31 (0.11–0.88) 0.027 0.70 (0.35–1.39) 0.304 1.44 (0.53–3.96) 0.476
CT 1.07 (0.73–1.58) 0.726 0.88 (0.60–1.28) 0.504 0.98 (0.72–1.34) 0.923 0.94 (0.57–1.57) 0.823
Dominant TT 1.00 1.00 1.00 1.00
CC-CT 1.17 (0.81–1.68) 0.412 0.80 (0.55–1.15) 0.223 0.94 (0.70–1.27) 0.703 1.01 (0.62–1.64) 0.968
Recessive CT-TT 1.00 1.00 1.00 1.00
CC 1.74 (0.84–3.59) 0.137 0.32 (0.11–0.91) 0.032 0.70 (0.35–1.38) 0.305 1.47 (0.54–3.98) 0.447
Additive 1.21 (0.90–1.61) 0.210 0.75 (0.55–1.03) 0.072 0.92 (0.71–1.17) 0.486 1.07 (0.73–1.57) 0.739

SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval

p values were calculated by logistic regression analysis with adjustment for age and gender

Bold values indicate statistical significance (p < 0.05)